Skip to main content

WELLS FARGO & COMPANY/MN

Position in SMMT — Summit Therapeutics Inc.

CIK 72971 SAN FRANCISCO, CA

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,036,576
+$755,670 QoQ
Shares Held
208,413
+73.2% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 242 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Sep 30, 2025
CallValue
$2,066
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. SMMT ranks #78 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,036,576 208,413
2026-03-31 $2,280,906 120,301
2025-12-31 $2,289,194 130,886
2025-09-30 $3,984,817 192,876
2025-09-30 $2,066 100
2025-06-30 $4,994,840 234,720
2025-03-31 $2,435,747 126,270
2024-12-31 $1,700,002 95,265
2024-09-30 $1,168,911 53,375
2024-09-30 $4,380 200
2024-06-30 $265,839 34,082
2024-03-31 $164,511 39,737
2023-12-31 $91,613 35,101
2023-09-30 $52,840 28,257
2023-06-30 $133,727 53,278
2023-03-31 $9,150 5,229
2022-12-31 $24,250 5,706
2022-09-30 $25,109 21,100
2022-06-30 $20,900 20,900
2022-03-31 $106,784 43,586
2021-12-31 $227,266 84,486
2021-09-30 $887,069 177,060
2021-06-30 $396,610 53,165
2021-03-31 $301,718 51,400
2020-12-31 $211,500 45,000
2020-09-30 $120,400 35,000